Danish investor snaps up Benchmark genetics business in £260 million deal
The acquisition is the second major aquaculture deal in as many months by the largest shareholder in Danish pharmaceutical giant Novo Nordisk.
The acquisition is the second major aquaculture deal in as many months by the largest shareholder in Danish pharmaceutical giant Novo Nordisk.